NOL Guided Analgesia for Spinal Surgery

This trial aims to determine if NOL (nociception level index) monitoring can improve pain management during and after spine surgery. It focuses on patients undergoing procedures like laminectomy, spinal fusion, or disc replacement under general anesthesia. The trial will assess whether NOL-guided intraoperative analgesia affects the amount of pain medication needed and the overall surgical experience. Suitable participants are those advised by a doctor to undergo spine surgery and who consent to general anesthesia. As an unphased trial, this study allows patients to contribute to innovative pain management research that could enhance surgical outcomes.

The trial does not specify if you need to stop taking your current medications, but it does exclude those who have used psychoactive drugs in the last 90 days or are currently using IV opioids. It's best to discuss your specific medications with the trial team.

Research has shown that using NOL (Nociception Level) monitoring to manage pain during surgery can be safe for patients. In studies where NOL guided anesthesia, patients often required smaller doses of fentanyl, a common pain medication. This method reduced the drug dose by about 25% compared to those without NOL guidance. Smaller doses are generally safer, leading to fewer side effects.

Moreover, patients experienced less pain after surgery with NOL. One study found that pain levels dropped by 33% in those with NOL-guided anesthesia compared to those without it. Lower pain levels typically result in fewer complications and a smoother recovery.

NOL guided intraoperative analgesia is unique because it uses a novel approach to manage pain during spinal surgery. Unlike traditional methods that rely on fixed doses of painkillers, this technique leverages real-time monitoring of a patient's nociception level (which is how the body processes pain) to tailor the analgesia dosage precisely. Researchers are excited about this method because it promises to improve pain management by minimizing over- or under-dosing, which could lead to faster recovery and fewer side effects for patients undergoing spinal surgery.

Research has shown that using the nociception level index (NOL) to guide pain relief can significantly improve pain management during and after spine surgery. One study demonstrated that NOL guidance reduced the amount of fentanyl needed during surgery by 25%. Another study found that patients experienced less pain post-surgery, with average pain scores of 3.0 compared to 5.0 for those without NOL-guided treatment. This trial will include a retrospective cohort arm, using data from the hospital's EMR system to compare outcomes. These findings suggest that NOL monitoring helps customize pain relief more effectively, potentially leading to better patient outcomes.²³⁶⁷⁸